The Dark Truth About AI Stocks
All the signs show the AI market is about to reverse. And unless you know what's really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too.
Donald Trump has sweeping plans for a second administration. Here's what he's proposed
WASHINGTON (AP) — Donald Trump has promised sweeping action in a second administration.
A promising schizophrenia drug showed mixed results. What does that mean for patients?
Some people who took a new schizophrenia drug for a year improved with only a few side effects, but many dropped out of the research, the company announced Thursday.
Bill Gates' Mysterious New AI Project Revealed - Ad
Tech expert Jeff Brown uncovers Bill Gates' latest AI project, Stargate, which Forbes claims could reshape everything we think we know about our world.
23andMe cuts 40% of its workforce and discontinues therapeutics division
NEW YORK (AP) — is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling genetic testing company attempts to slash costs.
Stock Of The Day: Is Pfizer Set Up To Rally?
Shares of Pfizer (PFE) may be about to reverse and head higher. They are both oversold and at a support level.
AI Market Shock Coming November 19th? - Ad
Jeff Brown predicts an AI market shift, potentially happening by November 19th, led by Bill Gates' Stargate project. Get ahead of the curve before the next AI market shock.
Trump Picks Dr. Oz, Who Says Seniors Should Give Medical Marijuana A Try, To Lead Centers For Medicare And Medicaid Services
Trump to nominate TV personality Dr. Oz as administrator Centers for Medicare and Medicaid Services. Oz, known for his TV show, will work with RFK Jr. to take on the illness industrial complex.
Eli Lilly Stock Eyes Worst Month Since February 2009: Is It Time To Buy The Dip?
Eli Lilly & Co. shares plunge 12.5% this month, worst since 2009, due to disappointing earnings and lowered guidance. The future remains uncertain.
Forget Nvidia, Apple, Tesla, and Google - Ad
Market Wizard Larry Benedict: "Forget 99% of stocks: It's possible to make all the money you need for a happy retirement with just this one."
Tackling estate planning in 7 basic steps
Estate planning is one of those tasks that makes almost any other job look appealing, no matter how lowly.
Moderna Remains Confident Despite Political Concerns Over Vaccine Safety and HHS Nomination
Moderna plans to prioritize new product approvals and oncology investments, as political concerns over Robert F. Kennedy Jr.'s HHS nomination weigh on vaccine stocks.
Early Warning: A Deep Crack Is Forming in the US Economy - Ad
Stocks are booming thanks to Trump's landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. "I've found a deep crack forming in the foundations of the US economy," he says. "And before too long, it could tear our country apart." It's critical you learn more today, BEFORE it impacts your money and your retirement.
Goldman Sachs Economist: Weight-Loss Drugs Could Be Key To US Economic Growth
A Goldman Sachs economist has suggested that the US economy could experience accelerated growth with increased use of GLP-1 weight-loss drugs like Ozempic.
What's Going On With Liver Disease Focused Vir Biotechnology Stock Is Friday?
Vir Biotechnology's Phase 2 study on hepatitis B treatments shows promising antigen loss rates, with up to 46% achieving seroclearance in key regimens.
Wavebot: The Automated Trading Tool for This Bull Market - Ad
October through December are historically among the most bullish months for crypto. WaveBot -- an automated trading tool that takes all the guesswork out of profiting in crypto. It trades key levels, buying dips and selling at the perfect time, 24/7. All you need to do is set it up. After that, WaveBot takes care of everything.
A Croatian corruption investigation snares the health minister and several others
ZAGREB, Croatia (AP) — Croatia's health minister and several others were detained on Friday on suspicion of corruption as part of an investigation launched by the European prosecutor's office, authorities said.
European committee takes a second look at Alzheimer's drug and now says it should be approved
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after .
Single Stock Blueprint Available Now - Ad
Market Wizard Larry Benedict is one of the most successful traders you'll ever meet...But he doesn't make money the traditional way. In short: It's a way to trade just one stock...And potentially make all the money you need to fast-track your retirement -- no matter what happens in the stock market.
Amgen Defends Its Investigational Monthly Weight Loss Injection After Analyst Cites MariTide's Impact on Bone Density
Amgen addresses safety concerns for its weight loss drug MariTide after new data suggests a potential 4% reduction in bone density at the highest dose.
Bird Flu Puts Teen In Critical Condition As Canada Reports First Human Case: What You Need To Know
Pfizer and Moderna are hustling to develop an mRNA bird flu vaccine, the same technology used in the companies' respective COVID-19 vaccines.
Have You Heard of Donald Trump's Project Crypto? - Ad
Donald Trump aims to be America's first crypto president. Declaring at the Bitcoin conference in Nashville that the U.S. would become ..."the crypto capital of the planet." But, there's a special coin he hasn't mentioned that could soar even higher.
Justice Department sues to block UnitedHealth Group's $3.3 billion purchase of Amedisys
NEW YORK (AP) — The Justice Department is suing to block UnitedHealth Group's $3.3 billion purchase of Amedisys, citing concerns the combination would hinder access to home health and hospice services in the U.S.
Struggling Genetic Testing Company 23andMe To Lay Off 40% Of Its Workforce, Discontinues All Therapeutic Programs
23andMe restructures, cutting 40% of its workforce and ending its therapeutic programs to save $35 million annually while exploring strategic alternatives.
Why Trump's Victory Could Fuel the Next AI Surge - Ad
Louis Navellier, tech investor and market veteran, believes Trump's return will drive a second AI boom. Get the top six stocks he recommends before they skyrocket.
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization.
Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analysts Warn
Moderna's stock faces a decline as analysts lower the price target to $90, citing weaker vaccine demand and concerns over upcoming COVID and RSV sales.
Buffett, Bloomberg, & 48 Congress Members Are Buying 1 Sector - Ad
Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, "The Walmart Family", Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market... The last time we saw the world's wealthiest investors move their cash into this corner of the market, Stocks exploded 2,020%, 5,609% Even as high as 8,437% in just ONE year. Now, it's all happening again.
HIV Drugmaker Gilead Reports Strongest Quarterly Performance Of 2024, Analysts Boost Price Target On Raised Outlook
Gilead stock surges after Q3 earnings beat estimates and raised FY 2024 guidance, with strong HIV drug sales and analyst upgrades boosting investor confidence.
CVS Health Q3 profit misses estimates, company names new leaders at 2 divisions
CVS Health fell short on third-quarter profit, but it posted strong sales and the health care giant shook up leadership under new CEO David Joyner that has sent shares plunging.
The Next Wave of Tech Is Beyond AI - Ad
Big Tech is currently making a series of peculiar investments in a few strange companies. In fact, Elon Musk says these investments are critical when it comes to solving the number one problem facing AI. Now, Silicon Valley legend Michael Robinson has identified two companies that could play a significant role in the solution. Their stocks just may be the key to AI 2.0.
Eczema Drug Developer Nektar Gains Analyst Confidence With 400% Upside Potential
Piper Sandler initiates coverage of Nektar Therapeutics, citing REZPEG's Treg-focused action as a potential breakthrough for Alopecia areata treatment.
Why Is Integra LifeSciences Stock Soaring On Monday?
Integra LifeSciences' Q3 results show adjusted EPS of $0.41 and revenue at $380.83 million. Codman segment grows 1%, while Tissue Tech sees a 3.6% decline.
This Weight Loss Drug Loophole Is Set to Make Investors Incredibly Wealthy - Ad
Thanks to this rare FDA loophole, the world's most in-demand weight loss drugs have effectively just gone "off patent" for a short amount of time... Creating a once-in-a-lifetime profit window for investors.
Teladoc Health Q3 Earnings: Revenue Beat, EPS Beat, Shares Jump 10%
Teladoc Health shares are moving higher in extended trading Wednesday after the company reported financial results for the third quarter that topped analyst expectations.
Eli Lilly Q3 Earnings: Mounjaro Sales More Than Double, Takes $2.98 Billion Hit To Profit, Cuts Annual Outlook, Stock Tanks
Eli Lilly's stock falls as Q3 earnings miss estimates. 2024 guidance lowered due to IPR&D costs.
Wall Street Legend Issues Inauguration Buy Alert - Ad
If you've underperformed this raging bull market, if you've lost money or missed out... this is your final chance to potentially profit.
LENZ Therapeutics' Investigational Drug For Age-Related Blindness Aces Pivotal China Trial, Analyst Says Data Readout May Strengthen Position For Ex-U.S. Partnerships
LENZ Therapeutics and Corxel Pharmaceuticals announced Phase 3 data for LNZ100, showing significant presbyopia improvements, supporting potential FDA approval.
Stakes Are High For Nebraska's Medical Marijuana Families: Why They're Pushing For Cannabis Legalization
Nebraska families push for medical cannabis legalization, citing urgent need for treatment options for severe conditions as ballot nears.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.